Air Liquide SA · EURONEXT:AI

Air Liquide SA — Investor Presentation (May 2008)

34 slides from Air Liquide SA's investor presentation, May 2008

  1. Slide 1: Healthcare / Homecare

    Healthcare / Homecare Jean-Marc de Royere / Olivier Petit Analyst meeting, Bobigny, May 2008

  2. Slide 2: Presenters: Jean-Marc de Royere and Olivier Petit

    Jean-Marc de Royere  Member of Air Liquide’s Executive Committee, in charge of Healthcare & Speciality Chemicals, since 2000. Olivier Petit  Vice President, Homecare business, since 2003. The world leader in industrial and medical gases 2

  3. Slide 3: Content

    Content 1. Healthcare at Air Liquide 2. Homecare 3. Conclusion and Q&A The world leader in industrial and medical gases 3

  4. Slide 4: Introduction: Innovate for life

    Introduction : « Innovate for life » Video The world leader in industrial and medical gases 4

  5. Slide 5: Air Liquide mission in Healthcare

    Air Liquide mission in Healthcare Improve the well being of patients, In both acute & chronic care ; Thanks to the dedication and skills of our people, with the best worldwide standards of quality, care and environmental protection. The world leader in industrial and medical gases 5

  6. Slide 6: Major markets

    Major markets US: US healthcare at 15% of GDP. Medicare Reform Total markets: €16 bn (2007 est.) -> Massive impact on the largest market Breakdown (2007 sales, € m ) (€5.5bn just for homecare) 20% Europe: Healthcare at 8-10% of GDP 50% Growing markets, from a smaller 30% base. Japan: Change coming A

  7. Slide 7: Specifics of Healthcare

    Specifics of Healthcare Regulated, from production to marketing State involvement in financing, operations and pricing Service intensive, both in acute care & in the community Complex information management around the patient : physician, payer, hospital, pharmacist,… Physicians drive innovatio

  8. Slide 8: Larger Healthcare Competitors

    Larger Healthcare Competitors (€m, 2007 ; USD/€ 1,37)  Air Liquide 1 592 As published  Apria 1 191 US homecare only  Lincare 1 165 US homecare only  Linde 983 Driven by Aga & BOC acquisitions. Divested INO therapeutics in 2007  Praxair 755 11% of total sales  Air Products 461 - just homecare (

  9. Slide 9: 2007 healthcare numbers

    2007 healthcare numbers -> €1,592m reported sales, +8.7% -> 63% of sales outside France, in over 30 countries -> Serving 8,000 hospitals & clinics, 300,000 homecare patients Business breakdown Geographic breakdown (2007 sales, € m ) (2007 sales, € m ) 17% 23% 37% 42% 41% 40% Med gases & equipment Ho

  10. Slide 10: Air Liquide's History

    Air Liquide’s History  1970s : - First Medical gases company, in France  1980s: - Air Liquide starts Homecare - Builds a significant medical franchise in Italy - Starts respiratory equipment for acute care  1990s : - A Healthcare division, from Canada to Australia - Adds medical hygiene to the ho

  11. Slide 11: Air Liquide Strategy in recent years (2000 => )

    Air Liquide Strategy in recent years (2000 => ) 1) North America: Divested US homecare operations, => Focus on medical gases 2) Consolidate position in Europe: - Completed n°1 position (Homecare & medgas in Germany & UK), Hygiene (Italy, Switz., Austria) 3) Lead in emerging Asia: - 1st Homecare acqu

  12. Slide 12: Recent acquisitions

    Recent acquisitions  2004 : Allertech (Greece) Arcana (Austria) Braun Meditech (Germany) Medical gases division of Messer Germany Unident (Switzerland)  2005 : Farmec (Italy) Rubel (Germany) Zuther & Hautmann (Germany) + VitalAire US divestiture  2006 : NSP (Germany) Aiolos (Sweden)  2007 : Alli

  13. Slide 13: The German campaign in Homecare

    The German campaign in Homecare = VA Head-Offices and agencies Head Office = 2004 Braun Meditech Hamburg 10-2005 Rubel (ex-DMC) 01-2006 Zuther Bremen 10-2006 NSP = 07-2007 Five former Berlin DMC companies Dortmund Leipzig  N°1 in Home respiratory market Dresden Köln with national coverage and 19% m

  14. Slide 14: ALMA 2007-2011

    ALMA 2007-2011  Be the recognized leader in our industry  8-12% annual sales growth objective  Alma objectives (Feb. 2007): - Consolidate European homecare industry - Focus on innovation in gases (« therapeutic gases ») - Expand homecare model to other conditions - Deploy expertise in new geograp

  15. Slide 15: Innovation 2007-2011

    Innovation 2007-2011  Critical care: - Anesthesia (Xenon, N20) - Intensive care (N0, Oxhel ) - Emergency units (Kalinox, new O2 cylinder) …  Chronic care: - COPD management - Sleep services - Non respiratory home services … These innovations will be on the market by 2010 with significant impact by

  16. Slide 16: International growth 2008-2012

    International growth 2008-2012  China & Japan Base in China, team in Japan  Central Europe & Russia Started in critical care, homecare  Gulf & South Asia Currently investigating opportunities  South America From an existing base Build-up ongoing ; these geographies will impact significantly by 2

  17. Slide 17: Organisation & Capabilities

    Organisation & Capabilities -> 7 200 payroll staff, with experienced executive management -> International business units (medical gases, homecare, hygiene) -> Over 300 branches and 30 industrial sites; GMP production -> 4 R&D centers -> 25 « Group Experts » The world leader in industrial and medica

  18. Slide 18: HOMECARE

    HOMECARE The world leader in industrial and medical gases 18

  19. Slide 19: COPD

    COPD Definition • Chronic Obstructive Pulmonary Disease: permanent incapacity of the lungs to perform normal gas exchange • major risk factors for COPD: smoking and age (i) • 80-90% of COPD deaths due to a strong smoking history • Smoking cessation is key to slow down the disease progression Epidemi

  20. Slide 20: COPD patients on LTOT

    COPD 2,5m COPD patients on LTOT in 2007 LTOT patients evolution / zone 10,5m estimated in 2025 --Europe Europe --North North&&South SouthAmerica America --Western Pacific Western Pacific --Japan Japan 2005: 2005:2.2m 2.2m Air AirLiquide Liquide7% 7%MS MS Developed 2025: 2025:3.5m 3.5m countries Deve

  21. Slide 21: Sleep Apnea Syndrom (SAS)

    Sleep Apnea Syndrom (SAS) Definition • Sleep disorder characterized by one or more pauses in breathing during sleep • 2 types of sleep apnea: Obstructive, Central • Several risk factors: obesity, sex (male), age (over 40), other diseases (diabetes, epilepsy, rheumatoid diseases, asthma…) • Studies s

  22. Slide 22: Sleep Apnea Syndrom: equipped patients

    Sleep Apnea Syndrom • Growth trend of equipped patients in developed countries will continue with improvement of diagnostic, understanding of SAS co morbidities and renewal market for CPAP & Masks • In emerging economies, awareness, diagnostic and financial improvement will drive the growth of the m

  23. Slide 23: Homecare respiratory market

    Homecare respiratory market Competition environment is organized between Gas and non-Gas players that are providing traditional respiratory services Total Market : € 9b APRIA LINCARE AL/VitalAire OTHERS TEIJIN PRAXAIR ROTECH PPS AIR PRODUCTS VIVISOL AHP LINDE Air Liquide : • 3rd largest homecare act

  24. Slide 24: Other chronic pathologies

    Other chronic pathologies Diabetes • High glucose rate in blood • 2 main forms of diabetes: •Type 1, or insulin-dependant, accounts for 10 to 15% of diabetic patients. •Type 2, formerly called non-insulin dependant, accounts for 85% to 90% of diabetic patients Epidemiology: • Diabetes reaches 246M p

  25. Slide 25: Other chronic conditions

    Other chronic conditions • Chronic pathologies represent great opportunities for long term service • Costs linked to chronic patient treatment represent an important part of public health spending, and a major economic and organizational challenge for the future as these patients will need to be sup

  26. Slide 26: Homecare Business Model

    Homecare Business Model  Service activity focusing on patients with chronic pathologies treated at home  HR intensive activity with complex administrative process  Reimbursement schemes vary from country to country  Range of chronic pathologies reimbursed  Heterogeneity in the scope of the serv

  27. Slide 27: Main environment changes

    Main environment changes The health care environment is changing with differences between developed and emerging economies. Challenges of the public health systems --Technical, Technical,medical, medical,economic economicand andsocial socialchallenges challenges --Rising Risinghealth healthcare care

  28. Slide 28: Main environment changes: organizational changes

    Main environment changes In developed countries Healthcare organization will face major organizational changes actually centered around hospital… Retirement Hospital Home HAD Hospital LTCF Home LTCF Home Retirement Home … in the future organized around specialized structures with coordination needs

  29. Slide 29: Major ruptures

    Major ruptures Homecare future evolution depends on some key ruptures  Prevention & early diagnostic  Foreseeable decrease number of practioners  Payers will be requesting proof of treatment efficiency and economic benefit  Major organizational changes of health system actually centred around ho

  30. Slide 30: 2007 - 2025 market & opportunities

    2007 - 2025 market & opportunities Market in 2007 (size of this bubble ~100M€) Market in 2025 AL presence in homecare in 2007 Canada Northern Europe UK Eastern Europe USA Western Europe Japan China India Brazil Australia Argentina The world leader in industrial and medical gases 30

  31. Slide 31: Homecare ambition

    Homecare ambition  Be the Worldwide leader for treatment of chronic patients at home  Improving quality of care and treatment compliance  Proposing new solutions • reinforcing our positioning as the link between patients and physicians • addressing health financing issues  Managing chronic patho

  32. Slide 32: 5-year Alma plan in Homecare

    5-year Alma plan in Homecare 1) Growth by Leadership on our core markets • Focus on respiratory activities : gain market share • Development of new activities on key European markets: new pathologies to be treated at home and new offers 2) Develop into new countries • Develop and strengthen our pres

  33. Slide 33: An organisation that addresses the specifics of Homecare

    With an organisation that addresses the specifics of Homecare  Fundamental characteristics:  Organisation:  Service based  Strong professionalism of our • patients orientated, teams logistics • Training, Medical education  Requiring qualified people (nurses, kyne..) • Technical expertise,  Tar

  34. Slide 34: Conclusion on Air Liquide in Healthcare

    Conclusion on Air Liquide in Healthcare - Growing needs, worldwide -> strong prospects - A 20+ year history -> familiar with the markets - Patient focus -> medical organisation -> medical research - Services supply chain -> dedicated homecare organisation - International approach -> global Business

Air Liquide — Investor Presentation (May 2008) on 6ix